While researchers have successfully bioengineered immune cells to attack certain cancers, tumors often actively suppress immune activity once these cells enter the body, limiting the effectiveness of these types of therapies.
Today, the UCLA Samueli School of Engineering reports on a recent UCLA research collaboration that developed an implantable device to help these therapeutic immune cells extend their fight against solid tumors and blood cancers.
Microbiology, Immunology & Molecular Genetics (MIMG) postdoctoral scholar Yan-Ruide “Charlie” Li is first author of the study, working alongside MIMG professor Lili Yang and co-leader Song Li, a professor of bioengineering at the UCLA Samueli School of Engineering.
Learn more about the device and how it works, here: https://samueli.ucla.edu/implantable-charging-station-boosts-fight-against-cancer/